Kilitch Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

Results View source PDF Explain this filing

KILITCH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹183.00

prior close

₹183.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-1.5% vs market

Pharmaceuticals peers, median of 157sector+0.0%-1.6% vs sector

On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 1.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.8

10m

-0.9

15m

-1.4

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6-0.1-1.5+0.0-1.6

Next day

-2.0+0.5-2.5-0.1-1.9

-3.0-0.3-2.7-0.9-2.1

-3.3-0.5-2.8-1.3-1.9

-0.5-0.8+0.3-1.6+1.1

+1.1-2.3+3.4-2.3+3.4

-4.3-2.8-1.5-2.9-1.4

15d

-8.5-4.9-3.6-3.1-5.4

-8.2-4.7-3.5-4.3-3.9

-7.9-7.7-0.2-5.6-2.3

-12.8-7.8-5.0-10.3-2.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kilitch Drugs (India) Limited has filed its financial results for the quarter and half-year ended September 30, 2025 with the stock exchange. This is a routine regulatory submission, typically covering Q2 FY2026 standalone and consolidated results. The announcement itself only confirms the filing; the actual numbers, including revenue, profit, margins, and segment performance, would be detailed in the attached results document.

Likely market impact

No immediate price impact from the filing notice alone. Investors should review the actual results document for revenue growth, profitability, and margin trends before drawing conclusions. The results may influence sentiment depending on whether they meet, beat, or miss market expectations.